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You probably weren’t thinking about your body’s cellular DNA repair systems the last time you 
sat on the beach in the bright sunshine. Fortunately, however, while you were subjecting your 
DNA to the harmful effects of ultraviolet light, your cells were busy repairing the damage. The 
idea that our genetic material could be damaged by the sun was not appreciated in the early 
days of molecular biology. When Watson and Crick discovered the structure of DNA in 1953 [1], 
it was assumed that DNA is fundamentally stable since it carries the blueprint of life. However, 
over 50 years of research have revealed that our DNA is under constant assault by sunlight, 
oxygen, radiation, various chemicals, and even our own cellular processes.  Cleverly, evolution 
has provided our cells with a diverse set of tools to repair the damage that Mother Nature 
causes. 
DNA repair processes restore the normal nucleotide sequence and DNA structure of the 
genome after damage [2]. These responses are highly varied and exquisitely regulated. DNA 
repair mechanisms are traditionally characterized by the type of damage repaired. A large 
variety of chemical modifications can alter normal DNA bases and either lead to mutations or 
block transcription if not repaired, and three distinct pathways exist to remove base damage. 
Base excision repair (BER) corrects DNA base alterations that do not distort the overall 
structure of the DNA helix such as bases damaged by oxidation resulting from normal cellular 
metabolism. While BER removes single damaged bases, nucleotide excision repair (NER) 
removes short segments of nucleotides (called oligonucleotides) containing damaged bases. 
NER responds to any alteration that distorts the DNA helix and is the mechanism responsible 
for repairing bulky base damage caused by carcinogenic chemicals such as benzo [a]pyrene 
(found in cigarette smoke and automobile exhaust) as well as covalent linkages between 
adjacent pyrimidine bases resulting from the ultraviolet (UV) component of sunlight. NER can be 
divided into two classes based on where the repair occurs.  NER occurring in DNA that is not 
undergoing transcription (i.e., most of the genome) is called global genome repair (GGR or GG-
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NER), while NER taking place in the transcribed strand of active genes is called transcription-
coupled repair (TCR or TC-NER). We will explore NER in more detail below. Mismatch repair 
(MMR) is another type of excision repair that specifically removes mispaired bases resulting 
from replication errors.  
DNA damage can also result in breaks in the DNA backbone, in one or both strands. Single-
strand breaks (SSBs) are efficiently repaired by a mechanism that shares common features with 
the later steps in BER.  Double-strand breaks (DSBs) are especially devastating since by 
definition there is no intact complementary strand to serve as a template for repair, and even 
one unrepaired DSB can be lethal [3]. In cells that have replicated their DNA prior to cell 
division, the missing information can be supplied by the duplicate copy, or sister chromatid, and 
DSBs in these cells are faithfully repaired by homologous recombination involving the exchange 
of strands of DNA between the two copies.  However, most cells in the body are non-dividing, 
and in these cells the major mechanism for repairing DSBs is by non-homologous end joining 
(NHEJ), which as the name implies involves joining two broken DNA ends together without a 
requirement for homologous sequence and which therefore has a high potential for loss of 
genetic information.  
Hereditary defects in DNA repair.  The biological consequences of defects or deficiencies in 
DNA repair are varied and often severe. Mutations in genes that encode DNA repair proteins 
cause a wide variety of rare inherited human syndromes that exhibit diverse clinical phenotypes. 
Most include a premature aging phenotype, either photosensitivity or increased sensitivity to 
ionizing radiation exposure, greatly increased cancer risk, or all three.  Nearly all hereditary 
DNA repair diseases are recessive, meaning that both copies of a gene must be mutated in 
order for the disease to develop. As a result, these diseases are extremely rare, collectively 
accounting for less than 5% of all human cancers [2]. The vast majority of human cancers are 
spontaneous (not inherited) and result from a combination of genetic and environmental 
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contributions. Identifying genetic variations in the normal population that increase risk of cancer 
is of considerable public health interest, and DNA repair genes are likely candidates. Elucidating 
the molecular mechanisms that underlie inherited defects in DNA repair will provide a 
framework for understanding the complex patterns of predisposing genetic variations that will 
surely emerge from large-scale studies of spontaneous human cancers.    
Diseases have been linked with defects in all types of DNA repair pathways.  For example, 
hereditary nonpolyposis colon cancer (HNPCC) results from defects in mismatch repair genes, 
and hereditary breast cancer is caused by mutations affecting the breast cancer-associated 
proteins BRCA1 or BRCA2 that play a role in DSB repair by homologous recombination. Here 
we describe in more detail the  devastating human disorders known to be caused by defects in 
nucleotide excision repair (Table 1). 
Xeroderma pigmentosum (XP). Although rare, XP is the most common of the DNA repair 
defective diseases and the most well known. In the United States the frequency of XP is 
approximately 1 case per 250,000 and in Japan the frequency is much higher at 1:40,000 [4]. 
The discovery of 26 XP children in one small mountain village in Guatemala [5] focused recent 
international attention on XP, but it was first described in 1874 [6] and was first shown to be 
caused by defects in NER in the late 1960s [7].  The most evident clinical features of XP are 
extreme sun sensitivity with marked thickening of the skin (“xeroderma”) together with changes 
in pigmentation (“pigmentosum”) and a very high incidence of skin cancers on sun-exposed 
regions of the body. Eye and neurological abnormalities are also common. XP patients can be 
subdivided into eight complementation groups, XP-A through -G plus XP-V, based on which 
gene is affected. Seven of the eight genes (XPA through XPG) are directly involved in NER, 
while the XPV (variant) gene product is a DNA polymerase that is involved in translesion 
synthesis past UV lesions.  
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Cockayne syndrome (CS). First described by Edward Cockayne in the 1930s [8], CS is a 
developmental disorder involving profound mental retardation, premature aging, and severe 
wasting that become evident within the first few years of life and lead to death in childhood. CS 
patients are also sun-sensitive, but unlike XP, do not develop skin cancers. CS most frequently 
arises from mutations in genes encoding the CSA and CSB proteins. Both proteins are required 
for TCR, suggesting that defective repair of lesions in active DNA may be causative for the 
disease. However, the exact cellular function of the CSB protein has not yet been determined, 
and the nature of its causative role in CS is further complicated by the surprising finding that a 
patient diagnosed with UV-sensitive syndrome, an extremely mild sun-sensitive disease without 
any of the severe clinical features of CS, completely lacks any CSB protein [9]. In rare cases, 
certain mutations in the XPB, XPD, and XPG genes lead to XP combined with CS. These 
XP/CS patients are profoundly affected, having clinical features of both disorders. 
Trichothiodystrophy (TTD). This syndrome is characterized by sulfur(“thio”)-deficient brittle 
hair (“tricho”) with malformed (“dystrophy”) hair shafts, fish-like scales on the skin, mental and 
physical retardation, and sun sensitivity in some complementation groups [10].  Mutations in the 
XPD and XPB genes have been found to cause the sun-sensitive form of TTD [11,12], but until 
recently, the molecular basis for a third sun-sensitive TTD complementation group, TTD-A, was 
unknown.  In 2004 the gene mutated in TTD-A was identified and shown to encode a tiny 
protein of only 71 amino acids (8 kDa)  [13]. Remarkably, the small TTDA protein is the tenth 
subunit of a key multi-protein complex called TFIIH that was first described as a transcription 
factor (TF) essential for transcription initiation by RNA polymerase II (RNAPII) [14] and was later 
found to be required for NER as well  [15]. The XPB and XPD proteins are also components of 
TFIIH, making it clear that compromised TFIIH defines the molecular basis for the sun-sensitive 
form of TTD.   
Nucleotide excision repair.  Much of our understanding of NER in humans has come from 
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studies of cells from XP and CS patients. NER (shown schematically in Figure 1) can be 
generally broken down into five steps: damage recognition and initiation of repair, helix opening 
and unwinding, incision on either side of the lesion, excision (release) of the damage-containing 
oligonucleotide, and DNA synthesis and ligation. GG-NER and TC-NER differ in how damage is 
recognized and also in biological outcome. GG-NER protects against mutations in the genome 
from replication of unrepaired lesions that could ultimately lead to cancer, while TC-NER 
ensures that genes are transcribed correctly and efficiently, a function that is now appreciated to 
be important in protecting against aging [16]. 
The NER machinery responds when DNA suffers damage that distorts its helical structure. DNA 
lesions caused by UV are the best example of this type of damage and have been extensively 
studied, since they are easy to generate in the lab, are stable in DNA, and are biologically 
important for any organism that is exposed to sunlight. Repair is initiated when the helix 
distortion is recognized by the XPC protein together with its partner hHR23B. Some less 
distorting lesions first require initial recognition by the DDB complex, which is mutated in XP-E 
cells.  The TFIIH complex is then recruited by XPC and is immediately joined by the XPA 
protein, the single-stranded DNA binding protein RPA, and the XPG protein. The XPB and XPD 
components of TFIIH are DNA helicases (named for ability to disrupt the double helix), and 
through their action TFIIH unwinds the DNA surrounding the lesion until a 30 nucleotide 
“bubble” is formed. RPA and XPA stabilize the DNA bubble and also help to position two 
endonucleases at the bubble junctions, where they serve as “scissors” to cut out the DNA 
damage. The first incision, on the 3' side of the bubble relative to the lesion, is made by XPG, 
which also coordinates the second incision on the 5' side of the bubble by the XPF protein and 
its partner ERCC1 [17,18]. A lesion-containing DNA fragment of 25-32 nucleotides is released, 
the gap is filled in by a DNA polymerase using the information from the intact complementary 
strand, and the remaining nick is sealed by a DNA ligase that restores the intact strand. 
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A major decision point in NER concerns how the enzymatic machinery “knows” which of the two 
DNA strands should be cleaved, or indeed whether cleavage should occur at all (which is only 
appropriate if a lesion is actually present).  Presumably some mechanism for lesion verification 
must be involved. The damage-binding protein XPA is likely to play a role, since it is essential 
for NER incisions.  However, as described below, new evidence suggests the possibility that the 
multi-functional TFIIH complex is also involved. 
Transcription-Coupled Repair. DNA that is undergoing transcription initiates NER in a 
different manner (Figure 1), since UV lesions directly block elongating RNAPII [19,20]. The 
original and still current model for TCR [21] postulates that RNAP blocked by a lesion in the 
DNA template is more efficiently recognized than the lesion itself, providing a potent signal for 
recruiting repair enzymes. This idea nicely explains how TCR occurs much more rapidly than 
GGR [21]. Consistent with different recognition signals, the XPC/hHR23B protein complex is not 
required for TCR [22,23], and instead the CSB protein has been implicated in initiation of TCR 
through recognition of stalled RNAP [24], probably in concert with XPG [25]. After the 
recognition step, however, it is not clear how the recruited DNA repair proteins gain access to 
the DNA lesion, since it is occluded by the stalled polymerase [26]. Backup of RNAP facilitated 
by the transcription elongation factor TFIIS is one proposed mechanism for removing the 
polymerase from the lesion [27]; however, CSB actually appears to prevent TFIIS action [28,29] 
and hence backup may be an alternative to TCR. Degradation of the arrested RNAP has also 
been proposed, but this is likely to be a last resort when TCR fails, rather than part of the 
mechanism [30]. Recent evidence suggests that TFIIH in the presence of XPG may function to 
remodel RNAPII in an ATP-dependent manner during TCR through large-scale conformational 
changes that allow access to the lesion without removal of the polymerase [25]. In any case, the 
subsequent steps of TC-NER evidently proceed in a manner similar to GG-NER, with the final 
outcome being the efficient generation of a lesion-free template for transcription. 
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TFIIH in Transcription. In addition to TCR, transcription and NER are linked by the separate 
involvement of TFIIH in both processes. In transcription initiation, TFIIH is required for 
unwinding the DNA helix at the transcription start site, and XPB is essential for this process. 
TFIIH also has kinase activity provided by its CAK kinase three-protein subunit, which 
phosphorylates the carboxyl-terminal domain (CTD) of RNAPII. CTD phosphorylation is required 
for the polymerase to escape the promoter and begin elongating the transcript. How TFIIH is 
shared between NER and transcription is an open question in the field.  Innovative imaging 
techniques have begun to answer this question by probing the dynamics of TFIIH in living cells. 
Cellular dynamics of DNA repair. Live-cell imaging is a powerful technique to probe the 
cellular responses of the NER machinery to DNA damage, and it has been used to demonstrate 
that the NER proteins do not appear to exist in a pre-assembled complex but rather assemble in 
an ordered fashion at sites of DNA damage [31]. In particular, the dynamic movements of the 
multi-functional TFIIH have been monitored in living cells by linking a TFIIH subunit to the green 
fluorescent protein (GFP) from jellyfish.  After photo-bleaching a portion of the cell’s nucleus 
with a laser, a population of fluorescently labeled proteins can be seen moving back into the 
bleached area over time, and the speed at which this repopulation takes place can be 
measured. Hoogstraten et. al. (2002) used live-cell imaging of GFP-labeled XPB to examine the 
crosstalk of TFIIH between transcription and repair and showed that TFIIH migrates freely in the 
nucleus, functioning in repair or transcription with different kinetics [32].  TFIIH molecules 
interact longer with NER sites than with transcription sites (5 minutes versus 10 seconds). This 
simple observation provided significant insight into the origin of TTD phenotypes. TTD-A cells 
were known to have low levels of TFIIH, but TFIIH isolated from these cells had normal in vitro 
enzymatic activities, suggesting that TFIIH stability rather than function might be compromised, 
and indeed the TTDA protein increases TFIIH stability [13]. The live-cell imaging result provided 
a framework to interpret this observation.  Since TFIIH molecules are recycled much more 
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rapidly during transcription than during NER, higher concentrations of TFIIH are required to 
efficiently carry out NER. Thus low levels of TFIIH have a more dramatic effect on NER than on 
transcription and would cause an apparent defect in transcription only in terminally differentiated 
tissues with high transcriptional loads such as hair and skin, which is what is observed in TTD 
patients.   
In this issue of PLoS Biology, Giglia-Mari et al. used live-cell imaging to explore the dynamic 
movements of TTDA and XPD [33]. TTDA (and XPD to a lesser extent) was shown to be 
present in two populations that move with different dynamics: one population was stably 
associated with TFIIH (slow moving), while the other population moved freely around the cell 
(fast moving), even shuttling between the nucleus and the cytoplasm. After UV irradiation, more 
of the TTDA was found to be slow moving, suggesting that TTDA particularly remains 
associated with TFIIH during NER. The authors established that in fact TTDA only associates 
with TFIIH during productive NER events by using a clever trick. They treated the cells with 
actinomycin D (ActD), a chemical that inserts into DNA and then damages it when exposed to 
blue light but that is not repaired by NER. The initial responders in NER, XPC and TFIIH 
(monitored with XPB-GFP), were recruited to the ActD lesions, but not TTDA or the later NER 
factors, XPA or ERCC1.  TTDA was not fooled by the ActD lesions, suggesting that TFIIH – and 
possibly TTDA itself – plays a role in lesion verification and the recruitment of subsequent NER 
factors. Two other recent observations also suggest involvement of TFIIH in lesion verification, 
perhaps involving XPB and/or XPD. The altered TFIIH in cells from XP-D/CS patients results in 
aberrant production of incisions at sites of transcription rather than at DNA lesions [34], and a 
recent crystallographic structure of an XPB homolog has revealed the surprising existence of a 
domain that recognizes damaged DNA [35]. 
Perspectives. The TFIIH complex sits at the crossroads of GG-NER, transcription, and TC-
NER (Figure 2). It has two distinct functions in initiation of transcription and a still-expanding 
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number of different functions in NER, certainly including opening of the helix to allow incision but 
perhaps also including lesion verification and even remodeling of the RNAP in TC-NER. 
Different defects in its multiple functions cause three different human syndromes: XP, XP/CS, 
and TTD. Determining the precise mechanisms of each of these functions will require high-
resolution structural information of TFIIH components and complexes, coupled with innovative 
biological experiments such as those that probe the dynamic movements of TFIIH within the 
cell. Such future investigations will provide further key insights into the molecular basis of 
human repair deficiency diseases that result in cancer predisposition and premature aging. 
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Figure 1.  Nucleotide excision repair schematic.  
When DNA is damaged by sunlight, the damage is recognized differently depending on whether 
the DNA is transcriptionally active (transcription-coupled repair) or not (global excision repair). 
After the initial recognition step, the damage is repaired in a similar manner with the final 
outcome being the restoration of the normal nucleotide sequence. A more detailed description is 
provided in the text. 
 
Figure 2.  TFIIH is a multi-functional protein complex.  
TFIIH participates in normal transcription, nucleotide excision repair, and transcription-coupled 
repair and has multiple functions in each of these processes.  A medium-resolution electron 
microscopy structure of the human TFIIH complex [36] shows that TFIIH forms a ring-like 
structure with a protrusion that contains the CAK kinase complex. 
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Table 1.  Human diseases caused by defects in nucleotide excision repair 
Human disease Genes Clinical features Molecular defect 
    
xeroderma 
pigmentosum (XP) 
XPA through G; 
XPV 
sun sensitivity; cancer; 
neurological defects 
nucleotide excision repair 
(NER); translesion synthesis 
Cockayne syndrome 
(CS) 
CSA; 
CSB; 
additional genes? 
sun sensitivity; post-natal 
developmental defects; 
neurological defects; 
premature aging 
transcription-coupled repair 
(TCR) 
XP/CS XPB, XPD, XPG both XP and CS both global and transcription-
coupled NER 
photosensitive 
trichothiodystrophy 
(TTD)  
XPB; 
XPD; 
TTDA 
sun sensitivity; post-natal 
developmental defects; 
premature aging; brittle hair; 
scaly skin 
nucleotide excision repair; 
transcription 
UV sensitive 
syndrome (UVsS) 
CSB; 
unknown gene 
sun sensitivity transcription-coupled repair 
    
 
